These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2077538)

  • 1. Evidence that circulating 6keto prostaglandin E1 causes the platelet defect of Bartter's syndrome.
    Clive DM; Stoff JS; Cardi M; MacIntyre DE; Brown RS; Salzman EW
    Prostaglandins Leukot Essent Fatty Acids; 1990 Dec; 41(4):251-8. PubMed ID: 2077538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS
    Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
    Watson ML; Gill JR; Branch RA; Oates JA; Brash AR
    Lancet; 1983 Aug; 2(8346):368-70. PubMed ID: 6135873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin?
    MacIntyre DE; Smith M; Levine L; Stoff JS; Stemerman M; Steer ML; Salzman EW; Brown RS
    Adv Prostaglandin Thromboxane Res; 1980; 7():1199-202. PubMed ID: 7369031
    [No Abstract]   [Full Text] [Related]  

  • 5. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's and Gitelman's syndromes: from gene to clinic.
    Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
    Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the pathogenesis of Bartter's syndrome.
    Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G
    Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome.
    Calò L; D'Angelo A; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
    Nephron; 1996; 72(4):570-3. PubMed ID: 8730423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
    Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
    Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin overproduction in Bartter's syndrome.
    Güllner HG; Cerletti C; Bartter FC; Smith JB; Gill JR
    Lancet; 1979 Oct; 2(8146):767-9. PubMed ID: 90861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Variant of Bartter's Syndrome.
    Punatar SB; Divyashree S; Jogi VM
    J Assoc Physicians India; 2015 Jul; 63(7):58-61. PubMed ID: 26731830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.
    Gill JR; Bartter FC
    Am J Med; 1978 Nov; 65(5):766-72. PubMed ID: 360836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-keto-prostaglandin E1 and Bartter's syndrome.
    Jackson EK; Goodman RP
    N Engl J Med; 1981 Jul; 305(5):287. PubMed ID: 7195465
    [No Abstract]   [Full Text] [Related]  

  • 15. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis.
    Ohlsson A; Sieck U; Cumming W; Akhtar M; Serenius F
    Acta Paediatr Scand; 1984 Nov; 73(6):868-74. PubMed ID: 6395627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome.
    Colussi G; Rombolà G; Airaghi C; De Ferrari ME; Minetti L
    Nephrol Dial Transplant; 1992; 7(9):896-901. PubMed ID: 1328936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.